Research and Markets (http://www.researchandmarkets.com/research/3fb8ql/dermatitis) has announced the addition of the "Dermatitis - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dermatitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Dermatitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Dermatitis - Overview
  5. Pipeline Products for Dermatitis - Comparative Analysis
  6. Dermatitis - Therapeutics under Development by Companies
  7. Dermatitis - Therapeutics under Investigation by Universities/Institutes
  8. Dermatitis - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Dermatitis - Products under Development by Companies
  13. Dermatitis - Products under Investigation by Universities/Institutes
  14. Dermatitis - Companies Involved in Therapeutics Development

Companies Mentioned - Sample List

  • 3SBio Inc.
  • Abeome Corporation
  • Accolade Pharma LLC
  • Aclaris Therapeutics, Inc.
  • China Biologic Products, Inc.
  • ChironWells GmbH
  • Chugai Pharmaceutical Co., Ltd.
  • Convoy Therapeutics, Inc.
  • Creabilis SA
  • Delenex Therapeutics AG
  • Dermira Inc.
  • Dr. August Wolff GmbH & Co. KG Arzneimittle
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • EpiPharm AG
  • F. Hoffmann-La Roche Ltd.
  • FAES Farma SA
  • Foamix Pharmaceuticals Ltd.
  • Ziarco Pharma Ltd

For more information visit http://www.researchandmarkets.com/research/3fb8ql/dermatitis

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: Immune Disorders